BioTwin is building the virtual twin platform for human biology. From a simple biological sample, the platform maps 30,000+ biomarkers into hundreds of proprietary Bio-Signatures across organs, conditions, biological states, and health scores. Each update enriches a longitudinal virtual twin capable of powering multiple products, from earlier cancer screening and clinical decision support to precision health, longevity, wellness, and performance. Cancer is BioTwin's first clinical proving ground, with breast and colorectal cancer screening decision-support pathways in authorized UAE clinical settings. The platform extends across oncology, neurology, cardiology, and organ-level health intelligence, while TwinMe commercializes non-medical wellness, longevity, and performance applications.